Shire’s ADHD patents are valid, rules Federal Circuit

25-09-2015

Shire’s ADHD patents are valid, rules Federal Circuit

Feng Yu / Shutterstock.com

A US appeals court has upheld a lower court ruling that patents owned by Shire covering an ADHD treatment drug are valid, but reversed a separate judgment that said pharmaceutical company Johnson Matthey induced infringement.


Shire; ADHD; Allergan; Mylan; Vyanse; ADHD; patents; amphetamine

LSIPR